Cellosaurus logo
expasy logo

Cellosaurus TU-1 (CVCL_M530)

[Text version]
Cell line name TU-1
Accession CVCL_M530
Resource Identification Initiative To cite this cell line use: TU-1 (RRID:CVCL_M530)
Comments Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
Cell type: Plasma cell; CL=CL_0000786.
Sequence variations
Disease Plasma cell myeloma (NCIt: C3242)
Multiple myeloma (ORDO: Orphanet_29073)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 59Y
Category Cancer cell line
Publications

CLPUB00455
Kari Koskela, Tarja-Terttu Pelliniemi, Kari Remes, Rocco Savino, Gennaro Ciliberto, Kari Pulkki;
Establishment of three new myeloma cell lines from bone marrow plasma cells: response to interleukin-6 and interleukin-6-antagonist.
(In conference) Proceedings of the Vth international workshop on multiple myeloma; pp.3.83-3.83; International Myeloma Foundation; La Baule; France (1995)

PubMed=9249875; DOI=10.3109/00365519709099401
Hanna Ollikainen, Stina M. Syrjanen, Kari Koskela, Tarja-Terttu Pelliniemi, Kari Pulkki;
p53 gene mutations are rare in patients but common in patient-originating cell lines in multiple myeloma.
Scand. J. Clin. Lab. Invest. 57:281-289(1997)

PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2
Hans Gunther Drexler, Yoshinobu Matsuo;
Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia.
Leuk. Res. 24:681-703(2000)

PubMed=11818668; DOI=10.1159/000046625
Kari Koskela, Tarja-Terttu Pelliniemi, Lauri J. Pelliniemi, Kari Remes, Karl-Ove Soderstrom, Kari Punnonen, Rajiv Kumar, Hanna Ollikainen, Kari Pulkki;
Autocrine production and synergistic growth-promoting activity of interleukin-6 and oncostatin M in a new human myeloma cell line TU-1.
Acta Haematol. 107:23-28(2002)

Cross-references
Cell line databases/resources cancercelllines; CVCL_M530
Encyclopedic resources Wikidata; Q54973321
Entry history
Entry creation05-Nov-2013
Last entry update14-Aug-2025
Version number16